Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Velcade and Adriamycin in Metastatic Breast Cancer
NCT00574236Phase 2Terminated
- Sponsor
- University of Wisconsin–Madison
- Start
- Aug 2006
- Primary completion
- Oct 2009
- Modality
- Small Molecules, Modified Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of bortezomib in breast cancer, sponsored by University of Wisconsin–Madison. Started Aug 2006; status: terminated.
02
Drugs
bortezomib
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00574236.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00574236.